Maclizumab Dexamethasone - a CD163 Targeting Antibody Drug Conjugate directed Macrophages for Treatment of NASH and AAH
The novel ADC inhibits NASH progression in terms of ballooning, fat accumulation and fibrosis
Published: 25th June 2019

Patents
- Intellectual property rights are held by: US9724426B2, CN102686612B and US9476890B2
IP Status
- Patented
Seeking
- Development partner
- Commercial partner
- Seeking investment